| Jeffrey O Cohen, MD | |
|
300 Carson St, Jonesboro, AR 72401-3104 | |
| (870) 932-1198 | |
| (870) 910-7700 |
| Full Name | Jeffrey O Cohen |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 300 Carson St, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710973979 | NPI | - | NPPES |
| 117434001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | C6812 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Bernards Medical Center | Jonesboro, AR | Hospital |
| Piggott Community Hospital | Piggott, AR | Hospital |
| Arkansas Methodist Medical Center | Paragould, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Bernards Hospital Inc. | 0941105480 | 146 |
| St Bernards Physician Clinics Inc | 7012311269 | 172 |
News Archive
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.
There are more than 870 million people who are hungry and malnourished around the world. As we look toward 2050, we will have a third more mouths to feed, which will further strain systems, the environment and communities. Building sustainable, specific and multi-sectoral responses to ending hunger, and creating a food- and nutrition-secure world are urgent.
Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
› Verified 7 days ago
| Entity Name | St Bernards Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336150374 PECOS PAC ID: 0941105480 Enrollment ID: O20050121000843 |
News Archive
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.
There are more than 870 million people who are hungry and malnourished around the world. As we look toward 2050, we will have a third more mouths to feed, which will further strain systems, the environment and communities. Building sustainable, specific and multi-sectoral responses to ending hunger, and creating a food- and nutrition-secure world are urgent.
Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
› Verified 7 days ago
| Entity Name | St Bernards Hospital Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396053096 PECOS PAC ID: 0941105480 Enrollment ID: O20101123000105 |
News Archive
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.
There are more than 870 million people who are hungry and malnourished around the world. As we look toward 2050, we will have a third more mouths to feed, which will further strain systems, the environment and communities. Building sustainable, specific and multi-sectoral responses to ending hunger, and creating a food- and nutrition-secure world are urgent.
Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
› Verified 7 days ago
| Entity Name | St. Bernards Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255632568 PECOS PAC ID: 8921287087 Enrollment ID: O20110121000828 |
News Archive
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.
There are more than 870 million people who are hungry and malnourished around the world. As we look toward 2050, we will have a third more mouths to feed, which will further strain systems, the environment and communities. Building sustainable, specific and multi-sectoral responses to ending hunger, and creating a food- and nutrition-secure world are urgent.
Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
› Verified 7 days ago
| Entity Name | St Bernards Physician Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447923438 PECOS PAC ID: 7012311269 Enrollment ID: O20210810001875 |
News Archive
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.
There are more than 870 million people who are hungry and malnourished around the world. As we look toward 2050, we will have a third more mouths to feed, which will further strain systems, the environment and communities. Building sustainable, specific and multi-sectoral responses to ending hunger, and creating a food- and nutrition-secure world are urgent.
Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey O Cohen, MD 300 Carson St, Jonesboro, AR 72401-3104 Ph: (870) 932-1198 | Jeffrey O Cohen, MD 300 Carson St, Jonesboro, AR 72401-3104 Ph: (870) 932-1198 |
News Archive
A pilot crop insurance project recently launched in Kenya, aims to compensate small-scale farmers when crops fail, in an effort to break the cycle of poverty, Business Daily reports.
There are more than 870 million people who are hungry and malnourished around the world. As we look toward 2050, we will have a third more mouths to feed, which will further strain systems, the environment and communities. Building sustainable, specific and multi-sectoral responses to ending hunger, and creating a food- and nutrition-secure world are urgent.
Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Early diagnosis of structural fetal abnormalities by ultrasound during the first trimester would give women the option of undergoing abortion at a safer time in their pregnancy, research indicates.
› Verified 7 days ago
Dr. Naveed Younis, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E Oak Ave, Jonesboro, AR 72401 Phone: 870-935-6729 | |
Leslie Mccasland, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2231 Hill Park Cove, Jonesboro, AR 72401 Phone: 870-333-2721 Fax: 870-333-2720 | |
Veryl D Hodges, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198 Fax: 870-910-7700 | |
Veronica Easton, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198 | |
William B Roth, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4800 E Johnson Ave, Jonesboro, AR 72405 Phone: 870-936-1000 Fax: 870-936-2038 | |
Dr. Roger Hill, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E Oak Ave., Jonesboro, AR 72401 Phone: 870-935-6729 Fax: 870-268-4410 | |
Michael D. Hightower, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 311 Matthews Ave, Jonesboro, AR 72401 Phone: 870-935-4150 Fax: 870-934-5368 |